Maternal Outcome in Women with Threatened Miscarriage

被引:0
|
作者
Naurin, Rozina [1 ]
Tahseen, Shazia [1 ]
Naurin, Rubina [1 ]
Sultana, Nayyer [1 ]
Mahmood, Zahid [1 ]
Majeed, Tayyaba [1 ]
机构
[1] Cent Pk Teaching Hosp, Obstet & Gynae Unit, Lahore, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2016年 / 10卷 / 01期
关键词
Threatened miscarriage; maternal outcome; p/v bleeding; cesarean section;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To determine the maternal outcome in women with threatened miscarriage Study Design: Descriptive study Place and duration of study: Obstetrics & Gynecology unit, Central Park Teaching Hospital, Lahore. 1st January 2015-31st December 2015 Methodology: Pregnant women with vaginal bleeding less than 24 weeks with single viable intrauterine pregnancy on ultrasonography were included in the study. Patients with multiple pregnancies, inevitable miscarriage, incomplete miscarriage and complete miscarriage were excluded. Results: A total of 64 cases fulfilling the inclusion/exclusion criteria were enrolled to determine the maternal outcome in cases of threatened miscarriage. Age distribution of the patients was done which shows 23(35.93%) were between 20-25 years, 26(40.63%) between 26-30 years and 15(23.44%) were between 31-35 years of age, mean and sd was calculated as 27.32+2.54 years. Gestational age of the patients (at the time of presentation) was calculated which shows 17(26.55%) were between 18-20(+7) weeks, 22(34.38%) between 21-22(+7) weeks and 25(39.07%) were between 23-24 weeks of gestation, mean and sd was 22.43+1.36 weeks. Frequency of maternal outcome in cases of threatened miscarriage revealed 25(25%) P/V leakage, 19(29,69%) had cesarean section and 37(57.81%) had hypertensive disorders. Some of the patients had multiple outcomes. Stratification of maternal outcome with regard to age of the patients was done, out of 16 cases of P.V leakage, 7(43.75%) were between 20-25 years, 5(31.25%) were between 26-30, 4(25%) were between 31-35 years, out of 19 cases of cesarean section 6(31.58%) were between 20-25 years, 7(36.84%) between 26-30 years and 6(31.58%) between 31-35 years while out of 37 cases of hypertensive disorders 13(35.14%) were between 20-25 years, 16(43.24%) between 26-30 years and 8(21.62%) were between 31-35 years of age. Conclusion: We concluded that the frequency of maternal outcome is higher in patient with threatened miscarriage and among them Hypertensive disorders are more common. So, it is recommended that every patient who presents with threatened miscarriage should be sorted out for maternal outcome. However, it is also required that every setup should have their surveillance in order to know the frequency of the problem.
引用
收藏
页码:273 / 275
页数:3
相关论文
共 50 条
  • [31] The outcome of pregnancy in women with unexplained recurrent miscarriage
    Seage, G.
    Horvath, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 : 72 - 72
  • [32] Progestogen for treating threatened miscarriage
    Wahabi, Hayfaa A.
    Fayed, Amel A.
    Esmaeil, Samia A.
    Al Zeidan, Rasmieh A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [33] The prevalence of threatened miscarriage in Malta
    Sammut, Lara
    Bezzina, Paul
    Gibbs, Vivien
    Baron, Yves Muscat
    Agius, Jean Calleja
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 24
  • [34] Treatment options for threatened miscarriage
    Qureshi, N. S.
    MATURITAS, 2009, 65 : S35 - S41
  • [35] Progestogen for treating threatened miscarriage
    Wahabi, Hayfaa A.
    Althagafi, Nuha F. Abed
    Elawad, Mamoun
    Al Zeidan, Rasmieh A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03):
  • [36] Dydrogesterone support in threatened miscarriage
    El-Zibdeh, Mazen Y.
    Yousef, Lama T.
    MATURITAS, 2009, 65 : S43 - S46
  • [37] Threatened miscarriage: evaluation and management
    Sotiriadis, A
    Papatheodorou, S
    Makrydimas, G
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7458): : 152 - 155
  • [38] Progestogen for treating threatened miscarriage
    Wahabi, H. A.
    Althagafi, Abed N. F.
    Elawad, M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03):
  • [39] Progestogen for treating threatened miscarriage
    Wahabi, Hayfaa A.
    Fayed, Amel A.
    Esmaeil, Samia A.
    Bahkali, Khawater Hassan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [40] Treatment of Threatened Miscarriage with Progestogens
    Bryce, Carl
    AMERICAN FAMILY PHYSICIAN, 2019, 100 (05) : 279 - 280